Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
International Journal of MS Care
|
December 23, 2017
Triaging Patients with Multiple Sclerosis in the Emergency Department: Room for Improvement
Hesham Abboud, Karin Mente, Meagan Seay, et al.
CNS Drugs
|
August 12, 2020
Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination
Crystal Zheng, Indrani Kar, Claire Kaori Chen, et al.
Journal of Neuroimmunology
|
May 10, 2024
Unilateral cortical autoimmune encephalitis: A case series and comparison to late-onset Rasmussen's encephalitis
Sophia Damman, Persen Sukpornchairak, Amit Ahituv, et al.
Multiple Sclerosis and Related Disorders
|
April 29, 2021
Progressive myelopathy in myelin oligodendrocyte glycoprotein antibody-associated disease: A new mimicker of progressive multiple sclerosis?
Samuel B Marcucci, Mohamed Elkasaby, Rosemarie Walch, et al.
Journal of Neurology
|
October 5, 2017
Neuronal autoantibodies: differentiating clinically relevant and clinically irrelevant results
Hesham Abboud, Ian Rossman, Maureen A Mealy, et al.
Journal of Neurology
|
September 5, 2021
Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders
Hesham Abboud, Andrea Salazar-Camelo, Naveen George, et al.
Neuromodulation : Journal of the International Neuromodulation Society
|
June 16, 2015
Socioeconomic Status May Impact Functional Outcome of Deep Brain Stimulation Surgery in Parkinson's Disease
Gencer Genc, Hesham Abboud, Srivadee Oravivattanakul, et al.
Journal of Neurology
|
January 3, 2021
NMDAR antibody encephalitis overlapping with CLIPPERS syndrome in a psoriasis patient on adalimumab
Talora Martin, Sean Duke, Veena Kumar, et al.
Journal of Neuroimmunology
|
February 19, 2021
COVID-19, HHV6 and MOG antibody: A perfect storm
Muruj Jumah, Farah Rahman, Mark Figgie, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 10, 2026
Real world predictors of hypogammaglobulinemia and serious infections in patients receiving ocrelizumab or ofatumumab for the treatment of multiple sclerosis: The REPLACE-MS study
Kiranpal Singh Sangha, Collin Jakubecz, Michelle Maynard, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
International Journal of MS Care
|
December 23, 2017
Triaging Patients with Multiple Sclerosis in the Emergency Department: Room for Improvement
Hesham Abboud, Karin Mente, Meagan Seay, et al.
CNS Drugs
|
August 12, 2020
Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination
Crystal Zheng, Indrani Kar, Claire Kaori Chen, et al.
Journal of Neuroimmunology
|
May 10, 2024
Unilateral cortical autoimmune encephalitis: A case series and comparison to late-onset Rasmussen's encephalitis
Sophia Damman, Persen Sukpornchairak, Amit Ahituv, et al.
Multiple Sclerosis and Related Disorders
|
April 29, 2021
Progressive myelopathy in myelin oligodendrocyte glycoprotein antibody-associated disease: A new mimicker of progressive multiple sclerosis?
Samuel B Marcucci, Mohamed Elkasaby, Rosemarie Walch, et al.
Journal of Neurology
|
October 5, 2017
Neuronal autoantibodies: differentiating clinically relevant and clinically irrelevant results
Hesham Abboud, Ian Rossman, Maureen A Mealy, et al.
Journal of Neurology
|
September 5, 2021
Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders
Hesham Abboud, Andrea Salazar-Camelo, Naveen George, et al.
Neuromodulation : Journal of the International Neuromodulation Society
|
June 16, 2015
Socioeconomic Status May Impact Functional Outcome of Deep Brain Stimulation Surgery in Parkinson's Disease
Gencer Genc, Hesham Abboud, Srivadee Oravivattanakul, et al.
Journal of Neurology
|
January 3, 2021
NMDAR antibody encephalitis overlapping with CLIPPERS syndrome in a psoriasis patient on adalimumab
Talora Martin, Sean Duke, Veena Kumar, et al.
Journal of Neuroimmunology
|
February 19, 2021
COVID-19, HHV6 and MOG antibody: A perfect storm
Muruj Jumah, Farah Rahman, Mark Figgie, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 10, 2026
Real world predictors of hypogammaglobulinemia and serious infections in patients receiving ocrelizumab or ofatumumab for the treatment of multiple sclerosis: The REPLACE-MS study
Kiranpal Singh Sangha, Collin Jakubecz, Michelle Maynard, et al.
Page
of 7